NCT03803124View on ClinicalTrials.gov

Effect of Tolvaptan on Renal Plasma Flow (RPF) and Glomerular Filtration Rate (GFR) in ADPKD

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 15, 2017

Study Completion Date

December 15, 2017

Conditions
Polycystic Kidney, Autosomal Dominant
Interventions
DRUG

Tolvaptan

1 tablet before renography

DRUG

Placebo

1 tablet before renography

Trial Locations (1)

7500

Departments of medical research and medicine, Holstebro

All Listed Sponsors
lead

Regional Hospital Holstebro

OTHER

NCT03803124 - Effect of Tolvaptan on Renal Plasma Flow (RPF) and Glomerular Filtration Rate (GFR) in ADPKD | Biotech Hunter | Biotech Hunter